Spatial analysis of cholangiocarcinoma in relation to diabetes mellitus and Opisthorchis viverrini infection in Northeast Thailand.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 May 2024
07 May 2024
Historique:
received:
18
12
2023
accepted:
03
05
2024
medline:
8
5
2024
pubmed:
8
5
2024
entrez:
7
5
2024
Statut:
epublish
Résumé
Cholangiocarcinoma (CCA) exhibits a heightened incidence in regions with a high prevalence of Opisthorchis viverrini infection, with previous studies suggesting an association with diabetes mellitus (DM). Our study aimed to investigate the spatial distribution of CCA in relation to O. viverrini infection and DM within high-risk populations in Northeast Thailand. Participants from 20 provinces underwent CCA screening through the Cholangiocarcinoma Screening and Care Program between 2013 and 2019. Health questionnaires collected data on O. viverrini infection and DM, while ultrasonography confirmed CCA diagnoses through histopathology. Multiple zero-inflated Poisson regression, accounting for covariates like age and gender, assessed associations of O. viverrini infection and DM with CCA. Bayesian spatial analysis methods explored spatial relationships. Among 263,588 participants, O. viverrini infection, DM, and CCA prevalence were 32.37%, 8.22%, and 0.36%, respectively. The raw standardized morbidity ratios for CCA was notably elevated in the Northeast's lower and upper regions. Coexistence of O. viverrini infection and DM correlated with CCA, particularly in males and those aged over 60 years, with a distribution along the Chi, Mun, and Songkhram Rivers. Our findings emphasize the association of the spatial distribution of O. viverrini infection and DM with high-risk CCA areas in Northeast Thailand. Thus, prioritizing CCA screening in regions with elevated O. viverrini infection and DM prevalence is recommended.
Identifiants
pubmed: 38714779
doi: 10.1038/s41598-024-61282-1
pii: 10.1038/s41598-024-61282-1
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10510Informations de copyright
© 2024. The Author(s).
Références
Sripa, B. & Pairojkul, C. Cholangiocarcinoma: lessons from Thailand. Curr. Opin. Gastroenterol. 24, 349–356. https://doi.org/10.1097/MOG.0b013e3282fbf9b3 (2008).
doi: 10.1097/MOG.0b013e3282fbf9b3
pubmed: 18408464
pmcid: 4130346
Chaiteerakij, R. et al. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: a nationwide study. World J. Gastroenterol. 23, 7160–7167. https://doi.org/10.3748/wjg.v23.i39.7160 (2017).
doi: 10.3748/wjg.v23.i39.7160
pubmed: 29093624
pmcid: 5656463
Treeprasertsuk, S. et al. A significant cancer burden and high mortality of intrahepatic cholangiocarcinoma in Thailand: a nationwide database study. BMC Gastroenterol. 17, 3. https://doi.org/10.1186/s12876-016-0565-6 (2017).
doi: 10.1186/s12876-016-0565-6
pubmed: 28056836
pmcid: 5216607
Watanapa, P. & Watanapa, W. B. Liver fluke-associated cholangiocarcinoma. Br. J. Surg. 89, 962–970. https://doi.org/10.1046/j.1365-2168.2002.02143.x (2002).
doi: 10.1046/j.1365-2168.2002.02143.x
pubmed: 12153620
Poomphakwaen, K. et al. Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study. Asian Pac. J. Cancer Prev. 10, 251–258 (2009).
pubmed: 19537893
Songserm, N. et al. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol. 36, e89-94. https://doi.org/10.1016/j.canep.2011.11.007 (2012).
doi: 10.1016/j.canep.2011.11.007
pubmed: 22189445
Sithithaworn, P., Yongvanit, P., Duenngai, K., Kiatsopit, N. & Pairojkul, C. Roles of liver fluke infection as risk factor for cholangiocarcinoma. J. Hepatobiliary Pancreat. Sci. 21, 301–308. https://doi.org/10.1002/jhbp.62 (2014).
doi: 10.1002/jhbp.62
pubmed: 24408775
Aung, W. P. P. et al. First report and molecular identification of Opisthorchis viverrini infection in human communities from Lower Myanmar. PLoS ONE 12, e0177130. https://doi.org/10.1371/journal.pone.0177130 (2017).
doi: 10.1371/journal.pone.0177130
pubmed: 28472153
pmcid: 5417708
Sithithaworn, P. et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol. Int. 61, 10–16. https://doi.org/10.1016/j.parint.2011.08.014 (2012).
doi: 10.1016/j.parint.2011.08.014
pubmed: 21893213
Sripa, B. et al. Opisthorchiasis and opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop. 120(Suppl 1), S158-168. https://doi.org/10.1016/j.actatropica.2010.07.006 (2011).
doi: 10.1016/j.actatropica.2010.07.006
pubmed: 20655862
Prasongwatana, J., Laummaunwai, P., Boonmars, T. & Pinlaor, S. Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid fish dishes–as part of a rational program for control of O. viverrini-associated cholangiocarcinoma. Parasitol. Res. 112, 1323–1327. https://doi.org/10.1007/s00436-012-3154-9 (2013).
doi: 10.1007/s00436-012-3154-9
pubmed: 23052784
Grundy-Warr, C. et al. Raw attitudes, wetland cultures, life-cycles: socio-cultural dynamics relating to Opisthorchis viverrini in the Mekong Basin. Parasitol Int 61, 65–70. https://doi.org/10.1016/j.parint.2011.06.015 (2012).
doi: 10.1016/j.parint.2011.06.015
pubmed: 21712097
Thaewnongiew, K. et al. Prevalence and risk factors for Opisthorchis viverrini infections in upper Northeast Thailand. Asian Pac. J. Cancer Prev. 15, 6609–6612. https://doi.org/10.7314/apjcp.2014.15.16.6609 (2014).
doi: 10.7314/apjcp.2014.15.16.6609
pubmed: 25169496
Saengsawang, P., Promthet, S. & Bradshaw, P. Reinfection by Opisthorchis viverrini after treatment with praziquantel. Asian Pac. J. Cancer Prev. 17, 857–862. https://doi.org/10.7314/apjcp.2016.17.2.857 (2016).
doi: 10.7314/apjcp.2016.17.2.857
pubmed: 26925692
Kamsa-ard, S. et al. Decreasing trends in cholangiocarcinoma incidence and relative survival in Khon Kaen, Thailand: an updated, inclusive, population-based cancer registry analysis for 1989–2018. PLOS ONE 16, e0246490. https://doi.org/10.1371/journal.pone.0246490 (2021).
doi: 10.1371/journal.pone.0246490
pubmed: 33592053
pmcid: 7886206
Kamsa-ard, S. et al. Risk factors for cholangiocarcinoma in thailand: a systematic review and meta-analysis. Asian Pac. J. Cancer Prev. 19, 605–614. https://doi.org/10.22034/apjcp.2018.19.3.605 (2018).
doi: 10.22034/apjcp.2018.19.3.605
pubmed: 29579789
pmcid: 5980830
Tyson, G. L. & El-Serag, H. B. Risk factors for cholangiocarcinoma. Hepatology 54, 173–184. https://doi.org/10.1002/hep.24351 (2011).
doi: 10.1002/hep.24351
pubmed: 21488076
Thinkhamrop, K. et al. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand. PLoS Negl. Trop. Dis. 15, e0009741. https://doi.org/10.1371/journal.pntd.0009741 (2021).
doi: 10.1371/journal.pntd.0009741
pubmed: 34543283
pmcid: 8452023
Thinkhamrop, K. et al. Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand. Sci. Rep. 10, 16855. https://doi.org/10.1038/s41598-020-73771-0 (2020).
doi: 10.1038/s41598-020-73771-0
pubmed: 33033306
pmcid: 7545164
Suwannatrai, A. T. et al. Bayesian spatial analysis of cholangiocarcinoma in Northeast Thailand. Sci. Rep. 9, 14263. https://doi.org/10.1038/s41598-019-50476-7 (2019).
doi: 10.1038/s41598-019-50476-7
pubmed: 31582774
pmcid: 6776517
Li, J., Han, T., Xu, L. & Luan, X. Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis. Prz. Gastroenterol. 10, 108–117. https://doi.org/10.5114/pg.2015.49004 (2015).
doi: 10.5114/pg.2015.49004
pubmed: 26557943
pmcid: 4631269
Tsai, M. S., Lee, P. H., Lin, C. L., Peng, C. L. & Kao, C. H. Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseases. Int. J. Cancer 136, 2409–2417. https://doi.org/10.1002/ijc.29292 (2015).
doi: 10.1002/ijc.29292
pubmed: 25348605
Saengboonmee, C., Seubwai, W., Lert-Itthiporn, W., Sanlung, T. & Wongkham, S. Association of Diabetes mellitus and cholangiocarcinoma: update of evidence and the effects of antidiabetic medication. Can. J. Diabetes https://doi.org/10.1016/j.jcjd.2020.09.008 (2020).
doi: 10.1016/j.jcjd.2020.09.008
pubmed: 33218924
Jing, W. et al. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur. J. Cancer Prev. 21, 24–31. https://doi.org/10.1097/CEJ.0b013e3283481d89 (2012).
doi: 10.1097/CEJ.0b013e3283481d89
pubmed: 21857525
Liu, R. Q. et al. Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors. Cancer Cell. Int. 13, 99. https://doi.org/10.1186/1475-2867-13-99 (2013).
doi: 10.1186/1475-2867-13-99
pubmed: 24139471
pmcid: 3852727
Thinkhamrop, K. et al. Associations between ultrasound screening findings and cholangiocarcinoma diagnosis in an at-risk population. Sci. Rep. 12, 13513. https://doi.org/10.1038/s41598-022-17794-9 (2022).
doi: 10.1038/s41598-022-17794-9
pubmed: 35933509
pmcid: 9357059
Khuntikeo, N. et al. Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer 15, 459. https://doi.org/10.1186/s12885-015-1475-7 (2015).
doi: 10.1186/s12885-015-1475-7
pubmed: 26054405
pmcid: 4459438
Alene, K. A., Viney, K., McBryde, E. S. & Clements, A. C. Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia. PloS ONE 12, e0171800. https://doi.org/10.1371/journal.pone.0171800 (2017).
doi: 10.1371/journal.pone.0171800
pubmed: 28182726
pmcid: 5300134
Restrepo, A. C., Baker, P. & Clements, A. C. National spatial and temporal patterns of notified dengue cases, Colombia 2007–2010. Trop Med Int Health 19, 863–871. https://doi.org/10.1111/tmi.12325 (2014).
doi: 10.1111/tmi.12325
pubmed: 24862214
Moungthard, H. et al. Association of cholangiocarcinoma among people with periductal fibrosis. Asian Pac. J. Cancer. Prev. 24, 4147–4154. https://doi.org/10.31557/APJCP.2023.24.12.4147 (2023).
doi: 10.31557/APJCP.2023.24.12.4147
pubmed: 38156850
pmcid: 10909088
Tawarungruang, C. et al. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification. BMC Cancer 21, 497. https://doi.org/10.1186/s12885-021-08247-z (2021).
doi: 10.1186/s12885-021-08247-z
pubmed: 33941120
pmcid: 8094526
Muthukumar, R. et al. Effects of Opisthorchis viverrini infection on glucose and lipid profiles in human hosts: a cross-sectional and prospective follow-up study from Thailand. Parasitol. Int. 75, 102000. https://doi.org/10.1016/j.parint.2019.102000 (2020).
doi: 10.1016/j.parint.2019.102000
pubmed: 31669292
Pengput, A. & Schwartz, D. G. Risk factors for Opisthorchis viverrini infection: a systematic review. J. Infect. Public Health 13, 1265–1273. https://doi.org/10.1016/j.jiph.2020.05.028 (2020).
doi: 10.1016/j.jiph.2020.05.028
pubmed: 32564936
Steele, J. A. et al. Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis. Infect. Dis. Poverty 7, 44. https://doi.org/10.1186/s40249-018-0434-3 (2018).
doi: 10.1186/s40249-018-0434-3
pubmed: 29769113
pmcid: 5956617